Cetylated Fatty Acid Composition With Reduced Antioxidant Content
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compositions of cetylated fatty acids for treating arthritis, inflammatory joint and musculoskeletal disorders, protecting gastric mucosa, and regulating blood glucose levels are not stable over time, have adverse effects, and are not economically viable due to high antioxidant content.
Innovation Solution
A composition comprising cetylated fatty acids with a reduced percentage of antioxidants (0.001% to 0.5% by weight) and optionally vegetable oil, prepared through a method involving an inert gas flow and vacuum program, ensuring stability and safety while maintaining efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If compositions contain high percentages of antioxidants (1% to 5% by weight), then stability over time is improved, but economic viability deteriorates due to high production costs
Solution Approach 1:
The patent changes the parameter of antioxidant concentration from the conventional 1-5% by weight to a reduced range of 0.01-0.5% by weight. This parameter optimization maintains sufficient stability while significantly improving economic viability, resolving the contradiction between stability and manufacturing cost.
2Productivity
If compositions are prepared without solvent and without heating ramps, then productivity is improved, but manufacturing precision deteriorates due to incomplete reaction
Solution Approach 1:
The patent replaces conventional thermal heating mechanisms with a catalytic system using zinc oxide and nitrogen gas flow. This substitution enables the reaction to proceed to completion without extensive heating, thereby maintaining both high productivity and complete reaction conversion.
Solution Approach 2:
The patent employs nitrogen gas as an inert atmosphere throughout the reaction process. This inert environment prevents unwanted side reactions and allows the esterification to proceed efficiently without solvent and with reduced thermal input, achieving both productivity and precision.
3Manufacturing precision
If compositions use conventional esterification methods with acid catalysts and aromatic hydrocarbon solvents, then manufacturing precision is improved, but object-generated harmful factors worsen due to catalyst residues and solvent effects
Solution Approach 1:
The patent extracts and eliminates the harmful components (aromatic hydrocarbon solvents and strong acid catalysts) from the conventional esterification system. By removing these harmful factors, the process achieves the same ester formation efficiency without the adverse effects of catalyst residues and solvent-related issues.
Solution Approach 2:
The patent replaces expensive, persistent harmful catalysts with a benign, easily removable zinc oxide catalyst that can be filtered out. This substitution maintains manufacturing precision while eliminating the harmful effects associated with traditional acid catalysts and aromatic solvents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition is stable, effective, and economically advantageous, providing rapid treatment for joint and musculoskeletal disorders, protecting gastric mucosa, and regulating blood glucose levels without adverse effects.
Implementation Method 1
applying a first heating ramp to said reaction mixture (15) up to reaching a temperature T1 comprised from 120° C. to 200° C. at a pressure P1 of about 1 atmosphere and in the presence of the inert gas flow to initiate an esterification reaction with initial formation of said cetylated fatty acid or mixture of cetylated fatty acids and esterification water
Implementation Method 2
applying a vacuum program in the chamber (3) which reduces the reaction pressure up to reaching a reduced pressure P2 comprised from 100 mbar to 10 mbar; followed by keeping said reaction mixture (15) under stirring at said reduced pressure P2 and in the presence of the inert gas flow for a period of time comprised from 30 minutes and 4 hours to obtain complete formation of said at least one unrefined cetylated fatty acid or mixture of unrefined cetylated fatty acids (MI)
Data Source
AI summary
A composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and an antioxidant in reduced percentages by weight, and related methods for treatment of arthritis and of inflammatory joint and musculoskeletal pain. Furthermore a composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and, optionally, an antioxidant, and related treatment methods for protecting the gastric mucosa and for regulating the blood glucose levels. Additionally, a method is described for preparing the at least one cetylated fatty acid or mixture of cetylated fatty acids and for preparing compositions comprising the cetylated fatty acids and the antioxidant.